Advanced Detection: The Sofia Influenza A+B Test utilizes cutting-edge immunofluorescence-based lateral-flow technology for the precise detection of influenza A and B viral nucleoprotein antigens.
CLIA Waived: Simplifies testing in various settings due to its waived status under the Clinical Laboratory Improvement Amendments (CLIA), indicating ease of use and reliability.
Comprehensive Kit: Each kit contains 75 tests, allowing for extensive testing coverage in medical facilities, clinics, and laboratories.
Efficient Diagnosis: Designed for rapid and accurate diagnosis of influenza A and B, aiding in timely treatment and patient care.
